In vitro profiling

Optimization of ADMET properties for lead structures and drug candidates by using state-of-the-art medium and high through-put in vitro DMPK and genotoxicological Assays.

contact

print

FINDING THE RIGHT DRUG CANDIDATE

We play a central role in multidisciplinary drug discovery projects by giving guidance of the chemical optimization through rapid learning cycles in a multidimensional space. We offer data fast, reliable and of highest quality and provide scientific support by explanation of results and the suggestion of appropriate screening strategies to overcome ADMET liabilities.

Our in vitro compound profiling services include state-of-the-art assays for in vitro metabolic stability (liver microsomes and hepatocytes), permeability and transporters, in vitro plasma protein binding, CYP inhibition (reversible and irreversible) and induction, phenotyping of drug metabolizing enzymes (I.e. CYPs, UGTs) as well as genotoxicity assays as non-GLP AMES and in vitro Micronucleus assay.

IDENTIFY AND OVERCOME ADME ASSOCIATED RISKS

We have a strong understanding of interpretation of these data in the specific project context and how to identify early and overcome DMPK related development risks, such as: absorption risks by using permeability assays, insufficient exposure using metabolic stability assays, prediction of drug-drug interaction (DDI) potential by inhibition and induction studies of CYP P450 enzymes as perpetrator and victim as well as risks associated with formations of reactive metabolite species or disproportionate drug metabolites performing in vitro metabolite ID studies.

close

This service is only available in the desktop version.

Our Services & Solutions along
the Drug Development Value Chain

Please click and choose a category

Discovery

PRECLINICAL

Clinical Phase I

Clinical Phase II

Overall Services

NUVISAN Overall Services along the Value Chain

API Manufacturig
(Non-GMP / GMP)

Formulation
Development

Pharmaceutical
Analysis

Bioanalysis
(Discovery and Regulated)

Biomarkers
(exploratory & GxP)

Translational
Pharmacology

Healthy Volunteers
& Patient Studies

Clinical Trial
Supplies

Regulatory
Affairs

Backend
Services

Corporate Project
Management

NUVISAN Overall Services along the Value Chain

API Manufacturig
(Non-GMP / GMP)

Formulation
Development

Pharmaceutical
Analysis

Bioanalysis
(Discovery and Regulated)

Biomarkers
(exploratory & GxP)

Translational
Pharmacology

Healthy Volunteers
& Patient Studies

Clinical Trial
Supplies

Regulatory
Affairs

Backend
Services

Corporate Project
Management

NUVISAN Overall Services along the Value Chain

API Manufacturig
(Non-GMP / GMP)

Formulation
Development

Pharmaceutical
Analysis

Bioanalysis
(Discovery and Regulated)

Biomarkers
(exploratory & GxP)

Translational
Pharmacology

Healthy Volunteers
& Patient Studies

Clinical Trial
Supplies

Regulatory
Affairs

Backend
Services

Corporate Project
Management

NUVISAN Overall Services along the Value Chain

API Manufacturig
(Non-GMP / GMP)

Formulation
Development

Pharmaceutical
Analysis

Bioanalysis
(Discovery and Regulated)

Biomarkers
(exploratory & GxP)

Translational
Pharmacology

Healthy Volunteers
& Patient Studies

Clinical Trial
Supplies

Regulatory
Affairs

Backend
Services

Corporate Project
Management

NUVISAN Overall Services along the Value Chain

API Manufacturig
(Non-GMP / GMP)

Formulation
Development

Pharmaceutical
Analysis

Bioanalysis
(Discovery and Regulated)

Biomarkers
(exploratory & GxP)

Translational
Pharmacology

Healthy Volunteers
& Patient Studies

Clinical Trial
Supplies

Regulatory
Affairs

Backend
Services

Corporate Project
Management

NUVISAN Overall Services along the Value Chain

API Manufacturig
(Non-GMP / GMP)

Formulation
Development

Pharmaceutical
Analysis

Bioanalysis
(Discovery and Regulated)

Biomarkers
(exploratory & GxP)

Translational
Pharmacology

Healthy Volunteers
& Patient Studies

Clinical Trial
Supplies

Regulatory
Affairs

Backend
Services

Corporate Project
Management